Management of paranasal sinus malignancy

Current Treatment Options in Oncology

Volumn 6, Issue 1, 2005, Pages 3-18

  Day, Terry A ^a   Beas, Ricardo A ^b   Schlosser, Rodney J ^b   Woodworth, Bradford A ^b   Barredo, Julio ^b   Sharma, Anand K ^b   Gillespie, M Boyd ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; TRANSCRIPTION FACTOR CDX2;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ALOPECIA; ANTINEOPLASTIC ACTIVITY; BLINDNESS; BONE NECROSIS; BRAIN NECROSIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CANCER SURGERY; CATARACT; CLINICAL TRIAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONJUNCTIVITIS; DIET THERAPY; DISEASE COURSE; DRY EYE; EDEMA; EPISTAXIS; ESTHESIONEUROBLASTOMA; ESTHETIC SURGERY; ETHMOID SINUS; FATIGUE; FISTULA; GAMMA KNIFE; HISTOPATHOLOGY; HUMAN; HYPOPITUITARISM; INCIDENCE; KERATITIS; LYMPH NODE METASTASIS; MAXILLARY SINUS; METAPLASIA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MYELITIS; NECK METASTASIS; NOSE CAVITY; NOSE CONGESTION; NOSE OBSTRUCTION; OPTIC NERVE DISEASE; PARANASAL SINUS CANCER; PROGNOSIS; RADIATION BEAM; RADIATION DERMATITIS; RADIATION DOSE; RECURRENCE RISK; RETINOPATHY; REVIEW; RHINORRHEA; RISK FACTOR; SARCOMA; SMOKING; SQUAMOUS CELL CARCINOMA; STEREOTAXIC SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TOPICAL ANESTHESIA; TREATMENT OUTCOME; TRISMUS; UNDIFFERENTIATED CARCINOMA; VISUAL SYSTEM;

EID: 13544273528     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-005-0009-y     Document Type: Review

References (99)

1. Batsakis JG: The pathology of head and neck tumors: nasal cavity and paranasal sinuses, part 5. Head Neck 1980, 2: 10-419.
2. Batsakis JG, Rice DH, Solomon AR: The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck 1980, 2:497-508.
3. Carrau RL, Myers RM, Johnson JT: Paranasal sinus carcinoma - diagnosis, treatment, and prognosis. Oncology (Huntingt) 1992, 6:43-50.
4. Resto VA, Deschler DG: Sinonasal malignancies. Otolaryngol Clin North Am 2004, 37:473-487.
5. Bhattacharyya N: Factors predicting survival for cancer of the ethmoid sinus. Am J Rhinol 2002, 16:281-286.
6. Greene FL, Page DL, Fleming ID, et al.: Cancer Staging Handbook, edn 6. New York: Springer-Verlag; 2003.
7. Leclerc A: Sinonasal cancer and wood dust exposure: results from a case-control study. Am J Epidemiol 1994, 140: 40-349.
8. Bussi M, Gervasio CF, Riontino E: Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. Acta Otolaryngol 2002, 122:197-201.
9. Gordon IP, Boffetta, Demers PA: A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers. Epidemiology 1998, 9:518-24.
10. Luce D, Leclerc A, Begin D, et al.: Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 2002, 13:147-157.
11. Van den Oever R: Occupational exposure to dust and sinonasal cancer. An analysis of 386 cases reported to the NCCSF Cancer Registry. Acta Otorhinolaryngol Belg 1996, 50:19-24.
12. Mannetje A, et al.: Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med, 1999, 36:101-107.
13. Myers LL, et al.: Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope 2002, 112:1964-1969.
14. Bhattacharyya N: Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 2002, 128:1079-1083.
15. Kresnik E, Mikosch P, Gallowitsch HJ, et al.: Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001, 28:816-821.
16. Helsel JC, Bardales RH, Mukunyadzi P: Fine-needle aspiration biopsy cytology of malignant neoplasms of the sinonasal tract. Cancer 2003, 99:105-112.
17. Perez P, Dominguez O, Gonzalez S, et al.: Ras gene mutations in ethmoid sinus adenocarcinoma: prognostic implications. Cancer 1999, 86:255-264.
18. Riazimand SH, Brieger J, Jacob R, et al.: Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization. Cancer Genet Cytogenet 2002, 136: 3-57.
19. Ariza M, Llorente JL, Alvarez-Marcas C, et al.: Comparative genomic hybridization in primary sinonasal adenocarcinomas. Cancer 2004, 100:335-341.
20. Martins C, Fonseca I, Roque L, et al.: Cytogenetic similarities between two types of salivary gland carcinomas: adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Cancer Genet Cytogenet 2001, 128:130-136.
21. Myers LL, Oxford LE: Differential diagnosis and treatment options in paranasal sinus cancers. Surg Oncol Clin N Am 2004, 13:167-186.
22. Samant S, Robbins KT, Vang M, et al.: Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cance.r Arch Otolaryngol Head Neck Surg 2004, 130:948-955.
23. Rischin D, Porceddu S, Peters L, et al.: Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 2004, 26:435-441.
24. Papadimitrakopoulou VA, Hong WK: Combined-modality therapy in paranasal sinus cancer. Cancer J Sci Am 1999, 5: 08-210.
25. Katz TS, Mendenhall WM, Morris CG, et al.: Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 2002, 24:821-829.
26. Dulguerov P, Jacobsen MS, Allal AS, et al.: Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001, 92: 012-3029.
27. Lee MM, Vokes EE, Rosen A, et al.: Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am 1999, 5:219-223.
28. Licitra L, Locati LD, Cavina R, et al.: Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003, 14:367-372.
29. Keles N, Erdamar B, Kaur A, Deger K: p21, p53, and p27, Kip1 alterations in benign and malignant tumors of sinonasal epithelium. Otolaryngol Head Neck Surg 2003, 129:77-84.
30. Pfister DG, Ang K, Brockstein B, et al.: National Comprehensive Cancer Network (NCCN) Practice Guidelines for Head and Neck Cancers. Oncology (Huntingt) 2000, 14:163-194.
31. National Comprehensive Cancer Network (NCCN): Practice Guidelines for Head and Neck Cancers. National Comprehensive Cancer Network, 2004. Accessible at http://nccn.org/. Accessed Ocotber 1, 2004.
32. Suarez C, Llorente JL, Fernandez De Leon R, et al.: Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004, 26:13 6-144.
33. Choi HR, Sturgis EM, Rashid A, et al.: Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol 2003, 34:1101-1107.
34. Barnes L: Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986, 10: 92-202.
35. Kennedy MT, et al.: Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004, 57:932-937.
36. Porceddu S, Martin J, Shanker G, et al.: Paranasal sinus tumors: Peter MacCallum Cancer Institute experience. Head Neck 2004, 26:322-330.
37. Wax MK, Burkey BB, Bascom D, et al.: Adenocarcinoma of the ethmoid sinus. Head Neck 1995, 17:303-311.
38. Bhattacharyya N: Survival and staging characteristics for nonsquamous cell malignancies of the maxillary sinus. Arch Otolaryngol Head Neck Surg 2003, 129:334-337.
39. Wiseman SM, Rigual NR, Hicks WL Jr, et al.: Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J 2002, 81:510-514.
40. Thompson LD, Wieneke JA, Miettinen M: Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003, 27: 94-611.
41. Dulguerov P, Calcaterra T: Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992, 102:843-849.
42. Kadish SM, Goodman, Wang CC: Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976, 37:1571-1576.
43. Hyams VJ: Tumors of The Upper Respiratory Tract and Ear. In Atlas of Tumor Pathology. Edited by BJ Hyams, VJ Michaels L. Washington, DC: Armed Forces Institute of Pathology; 1998:240-248.
44. McElroy EA Jr, Buckner JC, Lewis JE: Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998, 42:1023-1027.
45. Eich HT, Hero B, Staar S, et al.: Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage-C esthesioneuroblastoma. Strahlenther Onkol 2003, 179:233-240.
46. Eich HT, Hero B, Staar S, et al.: Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Int J Radiat Oncol Biol Phys 2002, 54:486-491.
47. Levine PA, Gallagher R, Cantrell RW: Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999, 109:1539-1543.
48. Koka VN, Julieron M, Bourhis J, et al.: Aesthesioneuroblastoma. J Laryngol Otol 1998, 112:628-633.
49. Franchi A, Moroni M, Massi D, et al.: Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol 2002, 26:1597-1604.
50. Jeng YM, Sung MT, Fang CL: Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 2002, 26:371-376.
51. Kim BS, Vongtama R, Juillard G: Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol 2004, 25:162-166.
52. Musy PY, Reibel JF, Levine PA: Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002, 112:1450-1455.
53. Hicks J, Flaitz C: Rhabdomyosarcoma of the head and neck in children. Oral Oncol 2002, 38:450-459.
54. Shapiro DN, Sublett JE, Li B, et al.: Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993, 53:5108-5112.
55. Scrable HJ, Witte DP, Lampkin BC, Cavenee WK: Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 1987, 329:645-647.
56. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al.: Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. The IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999, 33:362-371.
57. Kim GE, Koom WS, Yang WI, et al.: Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck 2004, 26:584-593.
58. Casanova M, Ferrari A, Gandola L, et al.: Undifferentiated nasopharyngeal carcinoma in children and adolescents: comparison between staging systems. Ann Oncol 2001, 12: 157-1162.
59. de Alava E, Gerald WL: Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000, 18:204-213.
60. Cope JU, Tsokos M, Miller RW: Ewing sarcoma and sinonasal neuroectodermal tumors as second malignant tumors after retinoblastoma and other neoplasms. Med Pediatr Oncol 2001, 36:290-294.
61. Levine PA, Debo RF, Meredith SD, et al.: Craniofacial resection at the University of Virginia (1976-1992): survival analysis. Head Neck 1994, 16:574-577.
62. Day TA, Davis BK: Skull-base reconstruction and rehabilitation. Otolaryngol Clin North Am 2001, 34: 241-1257.
63. Teknos TN, Smith JC, Day TA, et al.: Microvascular free-tissue transfer in reconstructing skull base defects: lessons learned. Laryngoscope 2002, 112:1871-1876.
64. Osguthorpe JD, Patel S: Craniofacial approaches to sinus malignancy. Otolaryngol Clin North Am 1995, 28:1239-1257.
65. Raveh J, Turk JB, Ladrach K, et al.: Extended anterior subcranial approach for skull base tumors: long-term results. J Neurosurg 1995, 82:1002-1010.
66. Moore CE, Ross DA, Marentette LJ: Subcranial approach to tumors of the anterior cranial base: analysis of current and traditional surgical techniques. Otolaryngol Head Neck Surg 1999, 120: 87-390.
67. Jho HD, Ha HG: Endoscopic endonasal skull-base surgery: part 1- the midline anterior fossa skull base. Minim Invasive Neurosurg 2004, 47:1-8.
68. Jho HD, Ha HG: Endoscopic endonasal skull base surgery: part 2- the cavernous sinus. Minim Invasive Neurosurg 2004, 47:9-15.
69. Liu JK, O'Neill B, Orlandi RR, et al.: Endoscopic-assisted craniofacial resection of esthesioneuroblastoma: minimizing facial incisions - technical note and report of three cases Minim Invasive Neurosurg 2003, 46:310-315.
70. London SD, Schlosser RJ, Gross CW: Endoscopic management of benign sinonasal tumors: a decade of experience. Am J Rhinol 2002, 16:221-227.
71. Devaiah AK, Larsen C, Tawfik O, et al.: Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection Laryngoscope 2003, 113:2086-2090.
72. Walch C, Stammberger H, Anderhuber W, et al.: The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000, 110:635-640.
73. Goffart Y, Jorissen M, Daele J, et al.: Minimally invasive endoscopic management of malignant sinonasal tumours. Acta Otorhinolaryngol Belg 2000, 54:221-232.
74. Polin RS, Sheehan JP, Chenelle AG, et al.: The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998, 42:1029-1037.
75. Hollinshead WH: Anatomy for Surgeons. In The Head and Neck edn 3. Philadelphia: JB Lippincott; 1982.
76. McHam SA, Adelstein DJ, Rybicki LA, et al.: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003, 25: 91-798.
77. Robbins KT, Clayman G, Levine PA, et al.: Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002, 128: 51-758.
78. Haylock BJ, John DG, Paterson IC: The treatment of squamous cell carcinoma of the paranasal sinuses. Clin Oncol (R Coll Radiol) 1991, 3:17-21.
79. Logue JP, Slevin NJ: Carcinoma of the nasal cavity and paranasal sinuses: an analysis of radical radiotherapy. Clin Oncol (R Coll Radiol) 1991, 3:84-89.
80. Neal AJ, Habib F, Hope-Stone HF: Carcinoma of the maxillary antrum treated by pre-operative radiotherapy or radical radiotherapy alone. J Laryngol Otol 1992, 106:063-1066.
81. Waldron JN, O'Sullivan B, Warde P, et al.: Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys 1998, 41:361-369.
82. Tsien C, Eisbruch A, McShan D, et al.: Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process. Int J Radiat Oncol Biol Phys 2003, 55: 76-784.
83. Prott FJ, Spitz J, Michaelis M, et al.: Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. Anticancer Res 2000, 20:3743-3749.
84. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE: Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003, 129:944-948.
85. Douglas JG, Silbergeld DL, Laramore GL: Gamma knife stereotactic radiosurgical boost for patients treated primarily with neutron radiotherapy for salivary gland neoplasms. Stereotact Funct Neurosurg 2004, 82:84-89.
86. Jiang GL, Ang KK, Peters LJ, et al.: Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 1991, 21:193-200.
87. Paulino AC, Fisher SG, Marks JE: Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus? Int J Radiat Oncol Biol Phys 1997, 39: 83-289.
88. Le QT, Fu KK, Kaplan M, et al.: Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Cancer 1999, 86: 700-1711.
89. Giri SP, Reddy EK, Gemer LS, et al.: Management of advanced squamous cell carcinomas of the maxillary sinus. Cancer 1992, 69:657-661.
90. Huang D, Xia P, Akazawa P, et al.: Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:158-168.
91. Claus F, De Gersem W, De Wagter C, et al.: An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int J Radiat Oncol Biol Phys 2001, 51:318-331.
92. Mock U, Georg D, Bogner J, et al.: Treatment planning comparison of conventional, 3-D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:147-154.
93. Forastiere AA, Goepfert H, Maor M, et al.: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349: 091-2098.
94. Cooper JS, Pajak TF, Forastiere AA, et al.: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
95. Bernier J, Domenge C, Ozsahin M, et al.: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350:1945-1952.
96. Adelstein DJ, Li Y, Adams GL, et al.: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003, 21:92-98.
97. Adelstein DJ, et al.: Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002, 20:1405-1410.
98. Rosen A, Vokes EE, Scher N, et al.: Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993, 119: 43-746.
99. Choi KN, Rotman M, Aziz H, et al.: Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. Int J Radiat Oncol Biol Phys 1997, 39:823-829.